Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Sep;19(5):384-90.
doi: 10.1097/ICU.0b013e328309f1a5.

Surgical management of retinopathy of prematurity

G Baker Hubbard 3rd  1
Affiliations
Review

Surgical management of retinopathy of prematurity

G Baker Hubbard 3rd. Curr Opin Ophthalmol. 2008 Sep.

Abstract

Purpose of review: The surgical management of retinopathy of prematurity continues to employ a paradigm of peripheral laser followed by vitrectomy for patients who develop retinal detachment. This review addresses significant advances that have been made in our understanding of the indications, timing, techniques, and outcomes of these interventions.

Recent findings: The indications for laser are highly dependent on the diagnosis of plus disease. Recognition of plus disease is variable and subjective. Efforts are underway to develop more objective measures of plus using image analysis software. Intravitreal injection of bevacizumab is emerging as an adjunct to laser for aggressive posterior retinopathy of prematurity. Although vitrectomy for retinal detachment is effective in eyes without plus, management of eyes with retinal detachment and persistent plus continues to be a major challenge. Older children with regressed retinopathy of prematurity may suffer from vitreous hemorrhage in the absence of retinal tears, detachments, or active neovascularization.

Summary: Our understanding of the best indications, timing, and techniques for the surgical management of retinopathy of prematurity continues to evolve and outcomes have improved in recent years. Areas that generate significant ongoing interest and investigation include the assessment of plus disease and the use of adjuncts for aggressive posterior retinopathy of prematurity.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cryotherapy for Retinopathy of Prematurity Cooperative G. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: preliminary results. Arch Ophthalmol. 1988;106:471–9. - PubMed
    1. Early Treatment For Retinopathy Of Prematurity Cooperative G. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121(12):1684–94. - PubMed
    1. Coats D, Saunders R. The dilemma of exercising clinical judgment in the treatment of retinopathy of prematurity. Arch Ophthalmol. 2005;123(3):408–9. discussion 9-10. - PubMed
    1. Fielder AR, Wilkinson AR. The further refinement of ROP treatment. commentary on the early treatment of retinopathy of prematurity study: structural findings at 2 years of age. Br J Ophthalmol. 2007;91(2):136–7. - PMC - PubMed
    1. Chiang MF, Jiang L, Gelman R, et al. Interexpert agreement of plus disease diagnosis in retinopathy of prematurity. Archives of Ophthalmology. 2007;125(7):875–80. - PubMed

    2. The authors find significant variability between experts in the diagnosis of plus disease as shown in fundus photographs.

Publication types